Insights

Partnership Expansion Acclinate is actively expanding its ecosystem through multiple partnerships with Egalitysciences and Advarra, signaling openness to collaborate with organizations that enhance minority representation in clinical research. This presents a sales opportunity to offer complementary services, data collaboration, or co-branded outreach campaigns to extend reach into underrepresented communities.

Community Engagement The NOWINCLUDED platform and mobile app demonstrate a strong emphasis on community-based health conversations and clinical trial awareness. This indicates a ready-made channel for patient recruitment, retention programs, and health education collaborations that could be monetized through sponsored content, targeted outreach, or tiered engagement solutions.

Media & Outreach New media initiatives like the NOWINCLUDED Unfiltered podcast and strategic press coverage highlight a growing brand voice and audience trust. There is potential to offer podcast sponsorship, branded content, and digital marketing services to extend reach into diverse communities and healthcare stakeholders.

Recognition & Growth Executive recognition such as Tiffany Whitlow’s inclusion in the 2026 Female Founders 500 enhances credibility for enterprise partnerships and larger collaborations. This can be leveraged in sales pitches to secure multi-year deals, channel partnerships, or co-development opportunities with larger biotech or healthtech buyers.

Scale Readiness With a revenue range of 25 to 50 million and proven funding support, Acclinate shows both financial maturity and growth ambition. This positions the company as a viable customer or partner for enterprise-grade data solutions, cloud-based analytics, security/compliance offerings, and scalable outreach platforms aligned with DEI in clinical research.

Similar companies to Acclinate

Acclinate Tech Stack

Acclinate uses 8 technology products and services including Apache Kafka, Tableau, GitHub, and more. Explore Acclinate's tech stack below.

Media & News

Acclinate's Email Address Formats

Acclinate uses at least 2 email formats:
Acclinate Email FormatsExamplePercentage
First@acclinate.comJohn@acclinate.com
98%
First.Last@acclinate.comJohn.Doe@acclinate.com
2%

Frequently Asked Questions

What is Acclinate's official website and social media links?

Minus sign iconPlus sign icon
Acclinate's official website is acclinate.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Acclinate generate?

Minus sign iconPlus sign icon
As of July 2026, Acclinate's annual revenue is estimated to be $25M - $50M.

What is Acclinate's SIC code and NAICS code?

Minus sign iconPlus sign icon
Acclinate's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Acclinate have currently?

Minus sign iconPlus sign icon
As of July 2026, Acclinate has approximately 60 employees across 1 continents, including North America. Key team members include Chief Development Officer: T. J., Director, Business Development: S. W. and Director Of Information Systems: D. S. Explore Acclinate's employee directory with LeadIQ.

What industry does Acclinate belong to?

Minus sign iconPlus sign icon
Acclinate operates in the Biotechnology Research industry.

What technology does Acclinate use?

Minus sign iconPlus sign icon
Acclinate's tech stack includes Apache Kafka, Tableau, GitHub, Docker, Kubernetes, Mailchimp, monday.com and Hootsuite.

What is Acclinate's email format?

Minus sign iconPlus sign icon
Acclinate's email format typically follows the pattern of First@acclinate.com. Find more Acclinate email formats with LeadIQ.

How much funding has Acclinate raised to date?

Minus sign iconPlus sign icon
As of July 2026, Acclinate has raised $14M in funding. The last funding round occurred on May 07, 2024 for $7M.

When was Acclinate founded?

Minus sign iconPlus sign icon
Acclinate was founded in 2020.
Acclinate logo

Acclinate

Biotechnology ResearchAlabama, United States51-200 Employees

Acclinate is a biotechnology research organization based in Birmingham, Alabama, dedicated to empowering underrepresented communities to take action for better health. The company combines advanced technology with grassroots engagement to connect communities, educate them, and support participation in health initiatives. Its NOWINCLUDED platform serves as a community hub to facilitate trusted health conversations and raise awareness about clinical trials.
Targeting diverse populations, Acclinate addresses gaps in access and information by expanding its community footprint through initiatives such as the NOWINCLUDED mobile app and related programs. In recent developments, the company has formed partnerships and launched new channels to widen audience access and integrate broader networks, aligning with its mission to broaden participation in health-focused research and education.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconFunding & Financials

  • $14M

    Acclinate has raised a total of $14M of funding over 7 rounds. Their latest funding round was raised on May 07, 2024 in the amount of $7M as a Series A.

  • $25M - $50M

    Acclinate's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.